Updated on: July 30, 2025
Endometrial cancer—the most common gynecologic malignancy in the U.S.—has a high survival rate when caught early. But for survivors, a personal history of endometrial cancer remains a critical piece of the medical narrative. Accurate documentation, appropriate follow-up care, and correct ICD-10 coding are essential for both clinical decision-making and administrative clarity.
In this article, we’ll cover:
-
What constitutes a personal history of endometrial cancer
-
When and how to use ICD-10 Z85.42
-
Surveillance, recurrence risk, and clinical documentation best practices
-
How DocScrib simplifies oncology documentation for providers
What Is Considered a “History of Endometrial Cancer”?
A personal history of endometrial cancer refers to a documented past diagnosis of cancer arising from the lining of the uterus, regardless of:
-
Current disease status (remission or cured)
-
Type of treatment received (surgery, radiation, chemo)
-
Time elapsed since diagnosis
The patient is not currently undergoing active treatment, but the cancer history continues to influence:
-
Surveillance plans
-
Risk for recurrence or secondary cancers
-
Medication selection (e.g., hormone replacement therapy contraindications)
-
Fertility, surgical, and imaging considerations
ICD-10 Coding: Z85.42 – Personal History of Endometrial Cancer
The ICD-10 code Z85.42 should be used to represent a history of malignant neoplasm of endometrium. It falls under:
-
Z85 – Personal history of malignant neoplasm
-
Specifically: Z85.42 – Personal history of malignant neoplasm of other parts of uterus
When to Use Z85.42
✅ The patient had endometrial cancer in the past
✅ They are no longer undergoing active cancer treatment
✅ Surveillance or risk factor management is being addressed
✅ The cancer diagnosis may affect treatment or medication plans
⚠️ Do not use Z85.42 if the patient is still receiving chemotherapy, radiation, or other active treatment—use a C54.x code instead for current malignancy.
Related ICD-10 Codes
ICD-10 Code | Description |
---|---|
Z85.42 | History of endometrial cancer (main code) |
C54.1 | Current cancer of endometrium |
Z90.71 | Acquired absence of uterus (post hysterectomy) |
Z08 | Follow-up after completed cancer treatment |
Z79.899 | Long-term drug therapy (e.g., hormonal therapy) |
Z80.41 | Family history of endometrial cancer |
Clinical Importance of Documenting Endometrial Cancer History
Endometrial cancer survivors require long-term follow-up. Accurately documenting their cancer history allows clinicians to:
-
Adjust care plans for potential recurrence or metastasis
-
Avoid prescribing estrogen-based therapies
-
Screen more proactively for secondary cancers (e.g., breast, colon)
-
Coordinate surveillance imaging, especially in patients with Lynch syndrome
Sample Documentation Template
Subjective:
“Patient reports she was diagnosed with Stage IA endometrial adenocarcinoma 5 years ago. Underwent total abdominal hysterectomy and radiation. No recurrence. Currently asymptomatic.”
Objective:
No abdominal tenderness. No vaginal bleeding. Pelvic exam deferred. Recent PAP/HPV negative. No lymphadenopathy.
Assessment:
-
History of endometrial cancer (Z85.42)
-
Status: No evidence of disease
-
No current treatment
-
Risk category: Low/intermediate
Plan:
-
Continue annual pelvic exams
-
Avoid estrogen therapy
-
Consider colonoscopy based on Lynch syndrome risk
-
Code: Z85.42 + Z90.71 (if uterus removed)
Risk of Recurrence and Clinical Follow-Up
While endometrial cancer is often curable, recurrence does occur—typically within 3 years. Recurrence sites include the vaginal cuff, pelvic lymph nodes, or lungs.
Risk Level | Recurrence Risk | Recommended Follow-Up |
---|---|---|
Low-risk (Stage I) | <5% | Annual physical/pelvic exam |
Intermediate | 5–15% | Pelvic exam every 3–6 months |
High-risk | >15% | Imaging + pelvic exam every 3 months |
Patients with History of Endometrial Cancer: Clinical Scenarios
Scenario 1: Post-Hysterectomy Surveillance
Use Z85.42 + Z90.71
Patient is disease-free, but surveillance is ongoing due to risk factors (e.g., obesity, hypertension, diabetes).
Scenario 2: Considering Hormone Replacement Therapy
Document Z85.42 to justify avoidance of estrogen, especially in patients with history of estrogen receptor-positive tumors.
Scenario 3: Lynch Syndrome or Family History
Consider adding Z80.41 – Family history of endometrial cancer or Z84.81 – Genetic susceptibility to neoplasm to guide cancer prevention efforts.
Why Accurate Coding and Documentation Matters
✅ Ensures appropriate surveillance and care coordination
✅ Triggers alerts for contraindicated treatments
✅ Supports accurate billing and audit readiness
✅ Protects against clinical oversight in medication planning
✅ Provides a complete longitudinal patient history
How DocScrib Streamlines Oncology Documentation
Capturing a history of endometrial cancer should be effortless—and with DocScrib, it is.
DocScrib Can Help Clinicians:
✅ Recognize and auto-suggest Z85.42 when a past cancer history is mentioned
✅ Automatically flag related codes like Z08, Z90.71, or Z79.899
✅ Generate templated follow-up notes for oncology and OB-GYN clinics
✅ Reduce documentation time by up to 70%
✅ Ensure coding compliance and complete problem list management
Experience AI-powered, oncology-aware documentation today.
👉 Book your free demo now
Quick ICD-10 Snapshot: History of Endometrial Cancer
Clinical Feature | ICD-10 Code(s) |
---|---|
History of endometrial cancer | Z85.42 |
Absence of uterus (post-surgery) | Z90.71 |
Follow-up after cancer treatment | Z08 |
Current endometrial cancer | C54.1 |
Long-term hormone therapy | Z79.899 |
FAQs
Q1: When is it appropriate to use Z85.42?
Use this code for any patient with a past diagnosis of endometrial cancer, who is not in active treatment, but whose history is relevant to their care.
Q2: Can I use Z85.42 along with Z90.71?
Yes. If the patient had a hysterectomy following cancer, Z90.71 helps document acquired absence of uterus.
Q3: How often should these patients be monitored?
Typically, low-risk patients are seen annually; high-risk patients may require visits every 3–6 months with imaging as needed.
Q4: Does DocScrib identify cancer history automatically?
Yes. DocScrib recognizes historical terms and flags relevant ICD-10 codes like Z85.42 and Z08 during live documentation.
Q5: Why does proper documentation matter post-cancer?
Beyond billing, it informs treatment decisions, screening frequency, and risk assessment for recurrence or secondary cancers.
Conclusion
A history of endometrial cancer should never be overlooked in clinical documentation. Whether it’s guiding surveillance, influencing medication decisions, or impacting OB-GYN care, correct use of ICD-10 Z85.42 helps clinicians provide accurate, informed, and coordinated care.
With AI-powered tools like DocScrib, documenting cancer history is smarter, faster, and more precise than ever before.